Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant Participants
ELSA
A Feasibility, Prospective, Repeated-measures, Within-subject, Interventional Study Investigating the Electrical Categorical Loudness Scaling Using the Mobile Research App in the Home and In-clinic Situation in Experienced Adult Cochlear Implant Participants
1 other identifier
interventional
20
2 countries
3
Brief Summary
This clinical study will evaluate a feature of the investigational Nexus Research System used for programming cochlear implants. Programming a cochlear implant-commonly referred to as MAP fitting-involves activating the device, allowing recipients to acclimatize to hearing sounds, and then fine-tuning the program based on the user's perception of loudness across different sounds. This process typically occurs over several visits and requires a clinician to collect data for the fine-tuning phase. The Nexus Research System includes an "Electrical Loudness Scaling" task, which participants can complete independently using a mobile application to collect the necessary data. Based on findings from previous studies, this feature has been revised to enable faster data collection. The current study will assess the performance of the updated feature. The study will involve experienced cochlear implant users. Participants will use the feature, undergo a series of hearing assessments-including evaluations of loudness perception-and provide feedback on the updated feature.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedStudy Start
First participant enrolled
October 21, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 24, 2025
CompletedJanuary 8, 2026
June 1, 2025
2 months
June 20, 2025
January 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in patient reported loudness rating scores for very soft sounds (loudness category 5) between Fast-ELS and Standard-ELS within one on-site session.
To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session on-site.
Day 0, Day 14
Change in patient reported loudness rating scores for loud sounds (loudness category 35) between Fast-ELS and Standard-ELS within one on-site session.
To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session on-site.
Day 0, Day 14
Change in patient reported loudness rating scores for very soft sounds (loudness category 5) between Fast-ELS and Standard-ELS within one at home session.
To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session at home.
Day 0 - Day 14
Change in patient reported loudness rating scores for loud sounds (loudness category 35) between Fast-ELS and Standard-ELS within one at home session.
To compare the accuracy of Fast-ELS and Standard-ELS obtained on MRA using a visual analogue scale within one session at home.
Day 0 - Day 14
Secondary Outcomes (8)
Correlation coefficient of very soft sounds (loudness category 5) obtained with Fast-ELS within one session on-site.
Day 0, Day 14
Correlation coefficient of very soft sounds (loudness category 5) obtained with Fast-ELS within one session at home.
Day 0 - Day 14
Correlation coefficient of loud sounds (loudness category 35) obtained with Fast-ELS within one session on-site.
Day 0, Day 14
Correlation coefficient of loud sounds (loudness category 35) obtained with Fast-ELS within one session at home.
Day 0 - Day 14
Correlation coefficient of very soft sounds (loudness category 5) obtained with Fast-ELS obtained during multiple sessions on-site.
14 days
- +3 more secondary outcomes
Study Arms (1)
Experimental: Participants receiving both Standard and Fast ELS task
EXPERIMENTALInterventions
The Fast-ELS task employs an algorithm to estimate the lower and upper bounds of the loudness range using a limited number of samples. This range is then refined by collecting additional samples across various loudness categories for comprehensive coverage.
The Standard-ELS task is conducted using the Mobile Research Application within the Nexus Research system. It is completed in two phases: the first phase identifies the lower and upper bounds of the loudness range based on participant ratings, while the second phase collects data from stimulations delivered within the established range.
Eligibility Criteria
You may qualify if:
- At least three months of experience with the cochlear implant.
- Implanted with the CI600 series (CI612, CI622, CI632) or CI500 series (CI512, CI522, CI532) cochlear implant.
- Able to be programmed with ACE (Advanced Combination Encoder), a fixed pulse width (PW) MAP with a maximum PW of 50 us per channel and with ≥ 18 enabled channels on the sound processor MAP.
- Fluent speaker in the language used to conduct the study procedures, as determined by the investigator.
- Willing and able to provide written informed consent and to comply with all requirements of the protocol.
You may not qualify if:
- Participants programmed with an acoustic component in the tested ear.
- Additional health factors, known to the investigator, that would prevent or restrict participation in the evaluations, including significant visual impairment and/or dexterity issues.
- Unable or unwilling to comply with the requirements of the clinical investigation as determined by the investigator.
- Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
- Cochlear employees or employees of Contract Research Organizations or contractors engaged by Cochlear for the purposes of this investigation.
- Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless Cochlear sponsored and determined by investigator or Sponsor to not impact this investigation).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cochlearlead
Study Sites (3)
Cochlear Denver Research Centre
Lone Tree, Colorado, 80124, United States
Cochlear Technology Centre Belgium
Mechelen, Mechelen, B-2800, Belgium
European Institute for Otorhinolaryngology (EIORL), ENT Department, Sint-Augustinus Antwerp
Antwerp, 2610, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Anke Plasmans
Cochlear Limited
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2025
First Posted
July 22, 2025
Study Start
October 21, 2025
Primary Completion
December 24, 2025
Study Completion
December 24, 2025
Last Updated
January 8, 2026
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share